PHE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cipher Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.1 EUR 1.83% Market Closed

Market Cap: €60.9m

C	Cipher Pharmaceuticals Inc SWB:PHE	CA
A	Abbott Laboratories XMUN:ABL	US
B	Boeing Co DUS:BCO	US
C	Cipher Pharmaceuticals Inc F:PHE	CA
V	Vinci SA F:SQU	FR

Profitability Summary

Cipher Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

81% > 81%

Exceptional Operating Margin

40%

Strong 3Y Average Operating Margin

36%

Declining Operating Margin

47% > 40%

Exceptional Net Margin

58%

Strong 3Y Average Net Margin

67%

Declining Net Margin

141% > 58%

Exceptional Free Cash Flow Margin

52%

Negative 3Y Average Free Cash Flow Margin

-16%

Declining Free Cash Flow Margin

65% > 52%

Positive ROE

24%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

35%

Declining ROIC

72% > 24%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.